Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimou

Showing results (521-530 of 610) with videos related to

Pageof 61
Sort By:
Hematological Oncology|February 21, 2017
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experienceMaria K Angelopoulou, Theodoros P Vassilakopoulos, Ioannis Batsis, et al.
Frontiers in Immunology|November 29, 2023
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responsesKatherine E R Smith, Kah-Whye Peng, Jose S Pulido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic MelanomaDouglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.
International Journal of Epidemiology|May 10, 2024
Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysisEmmanouil Bouras, Dipender Gill, Verena Zuber, et al.
Cancers|November 26, 2022
Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition StudyThu-Thi Pham, Katharina Nimptsch, Krasimira Aleksandrova, et al.
Nature Communications|February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trialTina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2021
Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization StudyNiki Dimou, James Yarmolinsky, Emmanouil Bouras, et al.
Open Forum Infectious Diseases|June 19, 2026
Postflood Leptospirosis Outbreak Response Due to <i>Leptospira interrogans</i> and <i>Leptospira kirschneri</i> in Central Greece, 2023: Comparison of Laboratory and Clinical ManifestationsZacharoula Bogogiannidou, Ioanna Voulgaridi, Maria Tseroni, et al.
European Journal of Pediatrics|January 12, 2024
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek populationStavroula Lampidi, Despoina Maritsi, Marietta Charakida, et al.
The Oncologist|January 23, 2025
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancerFerdinandos Skoulidis, Bob T Li, Maximilian Hochmair, et al.
Pageof 61

Showing results (521-530 of 610) with videos related to

Sort By:
Pageof 61
Hematological Oncology|February 21, 2017
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experienceMaria K Angelopoulou, Theodoros P Vassilakopoulos, Ioannis Batsis, et al.
Frontiers in Immunology|November 29, 2023
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responsesKatherine E R Smith, Kah-Whye Peng, Jose S Pulido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic MelanomaDouglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.
International Journal of Epidemiology|May 10, 2024
Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysisEmmanouil Bouras, Dipender Gill, Verena Zuber, et al.
Cancers|November 26, 2022
Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition StudyThu-Thi Pham, Katharina Nimptsch, Krasimira Aleksandrova, et al.
Nature Communications|February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trialTina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2021
Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization StudyNiki Dimou, James Yarmolinsky, Emmanouil Bouras, et al.
Open Forum Infectious Diseases|June 19, 2026
Postflood Leptospirosis Outbreak Response Due to <i>Leptospira interrogans</i> and <i>Leptospira kirschneri</i> in Central Greece, 2023: Comparison of Laboratory and Clinical ManifestationsZacharoula Bogogiannidou, Ioanna Voulgaridi, Maria Tseroni, et al.
European Journal of Pediatrics|January 12, 2024
Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek populationStavroula Lampidi, Despoina Maritsi, Marietta Charakida, et al.
The Oncologist|January 23, 2025
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancerFerdinandos Skoulidis, Bob T Li, Maximilian Hochmair, et al.
Pageof 61